Treatment of infantile neuroaxonal dystrophy with RT001: A di‐deuterated ethyl ester of linoleic acid: Report of two cases-Reference-Cited by-同舟云学术

Treatment of infantile neuroaxonal dystrophy with RT001: A di‐deuterated ethyl ester of linoleic acid: Report of two cases

Published:2020-03-27 Issue:1 Volume:54 Page:54-60
ISSN:2192-8312
Container-title:JIMD Reports
language:en
Short-container-title:JIMD Reports

Author:

Adams Darius¹,Midei Mark²^ORCID,Dastgir Jahannaz¹,Flora Christina¹,Molinari Robert J²,Heerinckx Frederic²,Endemann Sarah²,Atwal Paldeep²,Milner Peter²,Shchepinov Mikhail S.²

Affiliation:

1. Atlantic Health System Goryeb Children's Hospital Morristown New Jersey USA

2. Clinical Division Retrotope, Inc. Los Altos California USA

Funder

Retrotope

Publisher

Wiley

Subject

Biochemistry, Genetics and Molecular Biology (miscellaneous),Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmd2.12116

Reference16 articles.

1. INFANTILE NEUROAXONAL DYSTROPHY

2. Infantile neuroaxonal dystrophy

3. Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN)

4. Childhood disorders of neurodegeneration with brain iron accumulation (NBIA)

5. Infantile neuroaxonal dystrophy and PLA2G6-associated neurodegeneration: An update for the diagnosis

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the role of iPLA2β in neurodegeneration: From molecular mechanisms to advanced therapies;Pharmacological Research;2024-04

2. Arachidonic acid: reconciling the dichotomy of its oxidative cascade through specific deuteration;Free Radical Research;2023-10-28

3. Phenotype and genotype heterogeneity of PLA2G6-associated neurodegeneration in a cohort of pediatric and adult patients;Orphanet Journal of Rare Diseases;2023-07-05

4. Deuterated polyunsaturated fatty acids provided protection against oxidative stress in ocular fibroblasts derived from glaucoma patients;Mechanisms of Ageing and Development;2023-04

5. Emerging clinical investigational drugs for the treatment of amyotrophic lateral sclerosis;Expert Opinion on Investigational Drugs;2023-02-01